These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30724909)

  • 41. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
    Besser I; Perry ZH; Mesner O; Zmora E; Toker A
    Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperbilirubinemia in newborns with gestation ≥35 weeks.
    Sankaran K
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Oct; 12(10):761-6. PubMed ID: 20959036
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
    Olusanya BO; Ogunlesi TA; Kumar P; Boo NY; Iskander IF; de Almeida MF; Vaucher YE; Slusher TM
    BMC Pediatr; 2015 Apr; 15():39. PubMed ID: 25884679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supporting breastfeeding to reduce newborn readmissions for hyperbilirubinemia.
    Seagraves K; Brulte A; McNeely K; Pritham U
    Nurs Womens Health; 2013 Dec; 17(6):498-507. PubMed ID: 24589050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phototherapy for neonatal hyperbilirubinemia.
    Itoh S; Okada H; Kuboi T; Kusaka T
    Pediatr Int; 2017 Sep; 59(9):959-966. PubMed ID: 28563973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Uniform intervention criteria for jaundice in hyperbilirubinemia in preterm infants].
    van Imhoff DE; Dijk PH; Hulzebos CV;
    Ned Tijdschr Geneeskd; 2009; 153():A94. PubMed ID: 19785878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uniform treatment thresholds for hyperbilirubinemia in preterm infants: background and synopsis of a national guideline.
    van Imhoff DE; Dijk PH; Hulzebos CV;
    Early Hum Dev; 2011 Aug; 87(8):521-5. PubMed ID: 21621933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Routine administration of intravenous calcium during exchange blood transfusion for treatment of severe neonatal hyperbilirubinaemia: a systematic review of quantitative evidence protocol.
    Orimadegun AE; Akingbola TS
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):134-45. PubMed ID: 26447014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. JAMA patient page. Neonatal hyperbilirubinemia.
    Punnoose AR; Schwartz LA; Golub RM
    JAMA; 2012 May; 307(19):2115. PubMed ID: 22665118
    [No Abstract]   [Full Text] [Related]  

  • 50. Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
    Slaughter JL; Kemper AR; Newman TB
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35927519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thai healthy newborns have a higher risk.
    Jirapaet K
    J Med Assoc Thai; 2005 Sep; 88(9):1314-8. PubMed ID: 16536122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperbilirubinemia: current guidelines and emerging therapies.
    Schwartz HP; Haberman BE; Ruddy RM
    Pediatr Emerg Care; 2011 Sep; 27(9):884-9. PubMed ID: 21926893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing jaundice in infants of 35-week gestation and greater.
    Lease M; Whalen B
    Curr Opin Pediatr; 2010 Jun; 22(3):352-65. PubMed ID: 20463489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.
    Bromiker R; Goldberg A; Kaplan M
    J Perinatol; 2017 Dec; 37(12):1315-1318. PubMed ID: 29192695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?
    Baer VL; Hulse W; Bahr TM; Ilstrup SJ; Christensen RD
    J Perinatol; 2020 Feb; 40(2):352-353. PubMed ID: 31796840
    [No Abstract]   [Full Text] [Related]  

  • 56. Transcutaneous bilirubinometry in preterm neonates.
    Stillova L; Matasova K; Zibolen M; Stilla J; Kolarovszka H
    Indian Pediatr; 2009 May; 46(5):405-8. PubMed ID: 19179735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey.
    Hakan N; Zenciroglu A; Aydin M; Okumus N; Dursun A; Dilli D
    J Matern Fetal Neonatal Med; 2015 Sep; 28(13):1537-41. PubMed ID: 25182682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
    Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
    World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience.
    Kaplan M; Bromiker R; Schimmel MS; Algur N; Hammerman C
    J Pediatr; 2007 Apr; 150(4):412-7. PubMed ID: 17382121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of severe neonatal Hyperbilirubinaemia in a resource-limited setting: a 4-year longitudinal study in south-East Nigeria.
    Osuorah CDI; Ekwochi U; Asinobi IN
    BMC Pediatr; 2018 Jun; 18(1):202. PubMed ID: 29935542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.